Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 961 to 971 of 971 entries
Sorted by: Best Match Show Resources per page
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.

Oral oncology

Ferreira PS, Rocha L, Bezerra APC, Nico MMS, Lourenço SV.
PMID: 34929544
Oral Oncol. 2021 Dec 18;125:105674. doi: 10.1016/j.oraloncology.2021.105674. Epub 2021 Dec 18.

BACKGROUND: Actinic cheilitis (AC) presents as a diffuse clinical-histopathological alteration throughout the lower lip.OBJECTIVES: To analyze AC lesions using reflectance confocal microscopy (RCM) and evaluate criteria for the early diagnosis of incipient squamous cell carcinoma (SCC).METHODS: This prospective study...

Phenotypic reflection of white sponge nevus in histomorphological features of oral squamous cell carcinoma.

Oral oncology

Sarode G, Sarode SC, Sharma NK.
PMID: 35007880
Oral Oncol. 2022 Jan 07;125:105707. doi: 10.1016/j.oraloncology.2021.105707. Epub 2022 Jan 07.

No abstract available.

Chemotherapeutics-induced osteonecrosis of the jaw in a patient with acute promyelocytic leukemia: A rare case report.

Oral oncology

Wang L, Huang J, Tang Z.
PMID: 34891075
Oral Oncol. 2021 Dec 08;124:105659. doi: 10.1016/j.oraloncology.2021.105659. Epub 2021 Dec 08.

Medication related osteonecrosis of the jaw (MRONJ) is a commonly observed adverse reaction after taking anti-resorption and anti-angiogenic drugs. As we all know, arsenic compounds are used as drugs for pulp devitalization therapy and its local diffusion can cause...

MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.

Oral oncology

Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H.
PMID: 34896892
Oral Oncol. 2021 Dec 09;124:105666. doi: 10.1016/j.oraloncology.2021.105666. Epub 2021 Dec 09.

Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) have a poor prognosis. Recently, the use of immune checkpoint inhibitors (ICIs) for drug treatment has been expanding . However, the response rate to...

Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation.".

Oral oncology

Misra SR, Das R.
PMID: 34896893
Oral Oncol. 2021 Dec 09;124:105661. doi: 10.1016/j.oraloncology.2021.105661. Epub 2021 Dec 09.

No abstract available.

Sinonasal renal cell-like adenocarcinoma arising in von Hippel Lindau (VHL) syndrome.

Oral oncology

Maharaj S, Seegobin K, Wakeman K, Chang S, Potts K, Williams B, Redman R.
PMID: 34998175
Oral Oncol. 2022 Jan 05;125:105705. doi: 10.1016/j.oraloncology.2021.105705. Epub 2022 Jan 05.

Sinonasal renal cell-like adenocarcinoma (SNRCLA) is a rare and relatively novel diagnosis. Hereditary and somatic genomic signatures are not well defined in this disease. We report the case of a 35-year-old African-American male with von Hippel Lindau (VHL) syndrome...

Regarding the "The spiral ladder technique of facial nerve trunk identification during parotidectomy: A convenient roadmap for the beginners".

Oral oncology

Tretiakow D, Skorek A, Łapińska I.
PMID: 34971881
Oral Oncol. 2021 Dec 28;125:105695. doi: 10.1016/j.oraloncology.2021.105695. Epub 2021 Dec 28.

No abstract available.

Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis.

Oral oncology

Fiacchini G, Benettini G, Tricò D, Torregrossa L, Vianini M, Picariello M, Dallan I, Berrettini S, Bruschini L.
PMID: 33685817
Oral Oncol. 2021 Aug;119:105252. doi: 10.1016/j.oraloncology.2021.105252. Epub 2021 Mar 05.

This work examined published papers of patients affected by human papillomavirus-related head and neck adenosquamous carcinoma. Demographic data, tumor site and sub-site, TNM stage, HPV status (positive VS negative) and the technique used for its identification, the treatments performed,...

Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.

Oral oncology

Sari SY, Yilmaz MT, Aktas BY, Aksoy S, Gullu I, Cengiz M, Ozyigit G, Yazici G.
PMID: 34883400
Oral Oncol. 2021 Dec 06;124:105658. doi: 10.1016/j.oraloncology.2021.105658. Epub 2021 Dec 06.

OBJECTIVES: In metastatic and recurrent head and neck cancer (M/R HN-SCC), the median survival is less than a year and locoregional recurrence is the main cause of death. Our aim was to evaluate the results of concurrent stereotactic body...

MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.

Oral oncology

Noji R, Kano Y, Hirai H, Onishi I, Nishii N, Yoshimura R, Miyake S, Ikeda S, Harada H.
PMID: 34896892
Oral Oncol. 2021 Dec 09;124:105666. doi: 10.1016/j.oraloncology.2021.105666. Epub 2021 Dec 09.

Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) have a poor prognosis. Recently, the use of immune checkpoint inhibitors (ICIs) for drug treatment has been expanding . However, the response rate to...

Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation.".

Oral oncology

Misra SR, Das R.
PMID: 34896893
Oral Oncol. 2021 Dec 09;124:105661. doi: 10.1016/j.oraloncology.2021.105661. Epub 2021 Dec 09.

No abstract available.

Showing 961 to 971 of 971 entries